Nitric oxide and cardiopulmonary failure in sepsis

Respiratory-Circulatory Interactions in Health and Disease

Volumn , Issue , 2001, Pages 763-792

  Cohen, Rubin ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29744438582     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (175)

1. Stamler JS, Loh EL, Roddy M-A, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994; 89:2035-2040.
2. Lowenstein CL, Dinerman JL, Solomon HS. Nitric oxide: A physiologic messenger. Ann Intern Med 1994; 120:227-237.
3. Nathan C and Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78:915-918.
4. Fortier AH, Polsinelli T, Green SJ, Nacy CA. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect Immun 1992; 60:817-825.
5. Peng H-B, Libby P, Liao JK. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J Biol Chem 1995; 270:14214-14219.
6. Wink DA, Hanbauer I, Laval F, Cook JA, Krishna MC, Mitchell JB. Nitric oxide protects against the cytotoxic effects of reactive oxygen species. Ann NY Acad Sci 1994; 738:265-278.
7. Pannas D, Khadour FH, Szabo C, Schulz R. Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism. Am J Physiol 1998; 275:H1016-H1023.
8. Michel T, Feron O. Nitric oxide synthases: which, where, how and why. J Clin Invest 1997; 100:2146-2152.
9. Killbourn RG, Gross SS, Jubran A, Adams J, Griffith OW, Levi R, Lodato RF. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implication for involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87:3629-3632.
10. Moncada S. The L-arginine nitric oxide pathway. Acta Physiol Scand 1992; 145:201-227.
11. Gomez-Jimenez, Sagado A, Mourelle M, Martin MC, Segura RM, Peracaula R, Moncada S. L-arginine: Nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23:253-258.
12. Hollenberg SM, Cunnion RE, Zimmerberg J. Nitric oxide synthase responsiveness reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J physiol 1993; 254:H660-H663.
13. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142.
14. Stuher DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169:1543-1555.
15. Hibbs J Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deaminase and imino nitrogen oxidation to nitrite. Science 1987; 235:473-476.
16. Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985; 82:7738-7742.
17. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:621-626.
18. Lai CS, Komorov AM. Spintrapping of nitric oxide produced in vivo in septic-shock mice. FEBS Lett 1994; 345:120-124.
19. Kilbourn RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J, Lodato RF. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172:1132-1138.
20. Thiemermann C, Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo Eur J Phamacol 1990; 182:591-595.
21. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Valance P. Effects of nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28:34-39.
22. Teale Dm, Atkinson AM. Inhibition of nitric oxide synthase improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 1992; 30:839-842.
23. Rees DD, Monkhouse JE, Moncada S. NG-monomethyl-L-arginine HCl (L-NMMA:546C88) improves survival in a conscious instrumented mouse model of endotoxin shock. Endothelium 1995; 3:S116. Abstract 460.
24. Evans T, Carpenter A, Silva A, Cohen J. Inhibition of nitric oxide synthase in experimental gram-negative sepsis. J Infect Dis 1994; 169:343-349.
25. Lorente JA, Landin L, Renes E, Pablo R, Jorge P, Rodena E, Liste D. Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med 1993; 21:759-767.
26. Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA Jr. Detrimental effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994; 129:149-156.
27. Klabunde RE, Ritger RC. NG-monomethyl L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 1991; 178:1135-1140.
28. Saetre T, Smith AO, Schola T, Carlson H, Nordsletten L, Fahlstrom E, Aasen AO. Nitric oxide synthase inhibition reduces venous return in porcine endotoxemia. Am J Physiol 1996; 271:H1325-H1332.
29. Offner PJ, Robertson FM, Pruitt BA Jr. Effects of nitric oxide synthase inhibition on regional blood flow in a porcine model of endotoxic shock. J Trauma Injury Infect Crit Care 1995; 39:338-343.
30. Statman R, Cheng W, Cunningham JN, Henderson JL, Damiani P, Siconolfi A, Rogers D, Horovitz JH. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation. J Surg Res 1994; 57:93-98.
31. Jourdain M, Tournoys A, Leroy X, Mangalaboyi J, Fourrier F, Goudemand J, Gosselin B, Vallet B, Chopin C. Effects of Nω-nitro-L-arginine methyl ester on the endotoxin-induced disseminated intravascular coagulation in porcine septic shock. Crit Care Med 1997; 25:452-459.
32. Kilbourne RG, Szabo C, Traber D. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 1997; 7:235-246.
33. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57.
34. Cohen RI, Huberfeld S, Genovese J, Steinberg HN, Scharf SM. A comparison between the effects of nitric oxide synthase inhibition and fluid resuscitation on myocardial function and metabolism in endotoxemic dogs. J Crit Care 1996; 11:27-36.
35. Cohen RI, Chen L, Scharf SM. The effects of high dose NG-nitro-L-arginine -methyl ester on myocardial blood flow and left ventricular function in dogs. J Crit Care 1996; 11:206-213.
36. Cobb PJ, Natanson C, Hoffman WD, Lodato RF, Banks S, Kev CA, Solomon MA, Clin RJ, Hassan JM, Danger RL. Nω-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992; 176:1175-1182.
37. Cobb PJ, Natanson C, Caseate AM, William D, Hoffman WD, Kev C, Banks S, Cornea R, Levi R, Clin R, Hassan J, Danger RL. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol 1995; 268:H1634-H1642.
38. Freeman BD, Zeni F, Banks SM, Eichacker PQ, Bacher JD, Garvey Ep, Tuttle JV, Jurgensen BS, Natanson C, Danner RL. Response of the septic vasculature to prolonged vasopressor therapy with Nω-monomethyl-L-arginine and epinephrine in canines. Crit Care Med 1998; 26:877-885.
39. Kilbourn RG, Gromeens DM, Chelly FD, Griffith OW. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. Crit Care Med 1994; 22:1835-1840.
40. Cohen RI, Shapir Y, Chen L, Scharf SM. Right ventricular overload causes the decrease in cardiac output after nitric oxide synthesis inhibition in endotoxemia. Crit Care Med 1998; 26:738-747.
41. Strand AO, Leone AM, Giercksky K-E, Skovlund E, Kirkeboen KA. NG-monomethyl-Larginine improves survival in a pig model of abdominal sepsis. Crit Care Med 1998; 26:1490-1499.
42. Freeman BD, Cobb JP. Nitric oxide synthase as a therapeutic target in sepsis-more questions than answers? Crit Care Med 1998; 26:1469-1470.
43. Frostell C, Frattacci MD, Wain JC, Jones R, Zopol WM. Inhaled nitric oxide. A selective vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1992; 83:2038-2047.
44. Adatia I, Thompson J, Landberg M, Wessel DL. Inhaled nitric oxide in chronic lung disease. Lancet 1993; 341:307-308.
45. Roberts JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87:447-453.
46. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338:1173-1174.
47. Ogura H, Cioffi WG, Offner PJ, Jordan BS, Johnson AA, Pruitt BA. Effect of inhaled nitric oxide on pulmonary function after sepsis in a swine model. Surgery 1994; 116:313-321.
48. Offner PJ, Ogura H, Jordan BS, Pruitt BA, Cioffi WG. Effects of inhaled nitric oxide on right ventricular function in endotoxic shock. J Trauma 1995; 39:179-186.
49. Fierobe L, Brunet F, Dhainaut J-F, Monchi M, Belghith M, Mira J-P, Dall’ava-Santucci J, Dinh-Xuan TA. Effects of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151(5):1414-1419.
50. Klemm P, Thiemermann C, Winklmaier G, Martorana PA, Henning R. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxic shock. Br J Pharmacol 1995; 114:363-368.
51. Offner PJ, Ogura H, Jordan BS, Pruitt BA, Cioffi WG. Cardiopulmonary effects of combined nitric oxide inhibition and inhaled nitric oxide in porcine endotoxic shock. J Trauma 1996; 41:641-646.
52. Weitzberg E, Rudehill A, Modin A, Lundberg JM. Effect of combined nitric oxide inhalation and NG-nitro-L-arginine infusion in porcine endotoxic shock. Crit care Med 1995; 23:909-918.
53. Hinder F, Stubbe HD, Aken HV, Waurick R, Booke M, Meyer J. Role of nitric oxide in sepsis-associated pulmonary edema. Am J Respir Crit Care Med 1999; 159:252-257.
54. Stamler JS, Jia L, Eu JP, Mcmahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitroso-hemoglobin in the physiological oxygen gradient. Science 1997; 276:2034-2038.
55. Keaney JF Jr, Simon DI, Stamler JS, Jaraki Q, Scharfstein J, Vita JA, Losealgo J. NO forms an adduct with serum albumin that has endothelium-derived relaxing factr-like properties. J Clin Invest 1993; 91:1582-1589.
56. Jia L, Bonaventura C, Bonaventura A, Stamler JS. S-nitrosohemoglobin-a dynamic activity of blood involved in vascular control. Nature 1996; 380:221-226.
57. Lorente JA, Landin L, De Pablo R, Renes E, Liste D. L-arginine pathway in the sepsis syndrome. Crit Care Med 1993: 21:1287-1295.
58. Lin PJ, Chang C-H, Chang J-P. Reversal of refractory hypotension in septic shock by inhibitor of nitric oxide synthase. Chest 1994;106:626-629.
59. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-1558.
60. Locker GJ, Burgmann H, Staudinger T, Knapps S, Laczikas F, Fras M. Fatal cardiac side effecsts of L-NMMA? Crit Care Med 1996; 24:1930.
61. Grover R, Bakker J, Mcluckie A, Anderson J, LeGall J-R. The nitric oxide synthase inhibitor 546C88 promotes the resolution of shock in patients with severe sepsis. The Seventh World Congress of Intensive and Critical Care Medicine, Ottawa, Canada, June 29-July 3, 1997.
62. Szabo CS, Mitchell JA, Thiemermann C, Vane JR. Nitric oxide mediated hyporeactivity to norepinephrine precedes nitric oxide synthase induction in endotoxin shock. Br J Pharmacol 1993; 108:786-792.
63. Liu SF, Adock I, Old R, Barnes PJ, Evans TW. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun 1993; 196:1208-1213.
64. Liu SF, Adock IM, Old RW, Barnes PJ, Evans TW. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med 1996; 24:1219-1225.
65. Bateson An, Jakiwczyk OM, Schulz R. Rapid increase in inducible nitric oxide synthase gene expression in the heart during endotoxemia. Eur J Pharmacol 1996; 303:141-144.
66. Robinson NM, Westmore KR, Martin JF, Emson P, Charles IG: Inducible nitric oxide synthase transcription and protein activity in the rat heart during endotoxaemia. Biochem Biophys Res Commun 1997; 231:211-216.
67. MacMicking JD, Nathan C, Hom G, Chatrain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q-W, Sokol K, Huthchinson N, Cen H, Mudgett JS. Altered response to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641-650.
68. Wei X, Charles IG, Smih A, Ure J, Feng GJ, Huang FF, Xu D, Muller W, Moncada S, Liew FX. Altered immune responses in mice lacking inducible nitric oxidesynthase. Nature 1995; 375:408-411.
69. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 1995; 92:10688-10692.
70. Li XY, Donaldson K, MacNee W. Lipopolysaccharide-induced alveolar epithelial permeability. Am J Repir Crit Care Med 1998; 157:1027-1033.
71. Katsuya M, Nishina K, Tamada M, Takao Y, Maekawa N, Obara H. Aminoguanididne attenuates endotoxin-induced acute lung injury in rabbits. Crit Care Med 1198; 26:905-911.
72. Fang FC. Mechanism of nitric oxide-related antimicrobial activity. J Clin Invest 1997; 99:2818-2825.
73. Babu BR, Griffith OW: Design of isoform-selecive inhibitors of nitric oxide synthase. Curr Opin Chem Biol 1998; 2:491-500.
74. Olken N, Marletta M. NG-methyl-L-arginine functions as an alternative substrate and mechanism- based inhibitor of nitric oxide sythase. Biochemistry 1995; 32:9677-9685.
75. Griffiths M, Messent M, MacAllister R, Evans T. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 1993; 110:963-968.
76. Wu C-C, Ruetten H, Thiemermann C. Comparison of the effects of aminoguanidine and Nω-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxemia in the rat. Eur J Phamacol 1996; 300:99-104.
77. Szabo C, Southan G, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994; 91:12472-12476.
78. Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP. A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: a comparison with two nonselective strategies. Shock 1996; 5:116-121.
79. Rosselet A, Feihl F, Markert M, Gnaegi A, Perret C, Liaudet L. Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock. Am J Respir Crit Care Med 1998; 157:162-170.
80. Unno N, Wang H, Menconi M, Tytgat S, Larkin V, Smith M, Morin M, Chavez A, Hodin R, Fink MP. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in the rats. Gastroenterology 1997; 113:1246-1257.
81. Vos TA, Gouw A, Klok P, Havinga R, Goor HV, Huitema S, Roelofsen H, Kuipers F, Jansen P, Moshage H. Differential effects of nitric oxide synthase inhibitors on endotoxininduced liver damage in rats. Gastroenterology 1997; 113:1323-1333.
82. Bautista AP, Spitzer JJ. Inhibition of nitric oxide formation in vivo enhances superoxide release by the perfused liver. Am J physiol 1994; 266:G783-G788.
83. Cohen RI, Shapir Y, Davis A, Loona R, Scharf SM. Comparison between selective and nonselective nitric oxide synthase inhibition and phenylephrine in normal and endotoxic swine. Crit Care Med 2000; 28:3257-3267.
84. Saetre T, Gundersen Y, Thiemermann C, Lilleaasen P, Aasen A. Aminoethyl-isothiourea, a selective inhibitor of inducible nitric oxide synthase activity, improves liver circulation and oxygen metabolism in a porcine model of endotoxemia. Shock 1998; 9:109-115.
85. Wray GM, Millar CG, Hinds CJ, Thiemermann C. Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock 1998; 9:329-335.
86. Teale DM, Atkinson AM. L-canavanine restores blood pressure in a rat model of endotoxic shock. Eur J Pharmacol 1994; 271:87-92.
87. Liaudet L, Fishman D, Markert M, Perret C, Feihl F. L-canavanine improves organ function and tissue adenosine triphosphate levels in rodent endotoxemia. Am J Respir Crit Care Med 1997; 155:1643-1648.
88. Fishman D, Liaudet L, Lazor R, Perret C, Feihl F. L-canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats. Crit Care Med 1997; 25:469-475.
89. Stuehr D, Griffith OW. Mammalian nitric oxide synthases. Adv Enzymol 1992; 65:287-346.
90. Nussler A, Biliar T, Liu Z, Morris S. Co-induction of nitric oxide synthase and argininosuccinate synthases in murine macrophage cell line. J Biol Chem 1994; 269:1257-1261.
91. Hattori Y, Campbell E, Gross S. Argininosuccinate synthetase mRNA and activity are induced by immunostimulants in vascular smooth muscle: role in the regeneration of arginine for nitric oxide synthesis. J Biol Chem 1994; 269:9405-9408.
92. Heyland DK, Cook DJ, Guyatt G. Does the formulation of enteral feeding products influence infectious morbidity and mortality rates in the critically ill patient? A critical review of the evidence. Crit Care Med 1994; 22:1192-1202.
93. Stamler JS, Gow AJ. Reactions betwen nitric oxide and haemoglobin under physiological conditions. Nature 1998; 391:169-173.
94. Bone H, Schenarts P, Mcguire R, Cindrick L Fisher S, Booke M. Modified hemoglobin causes a redistribution of blood in the myocardium during ovine sepsis. Crit Care Med 1996; 24:A99.
95. Hinder F, Brooke M, Traber L, Matsumoto N, Nishida K, Rogers S. Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically elevated atrial naturiuretic peptide. Crit Care Med 1996; 24:131-136.
96. Bone H, Brooke M, Traber L, Spaulding T, Traber D. Nitric oxide synthase inhibition versus nitric oxide scavanging in sepsis. Circulation 1995; 92:I-46.
97. Herald HH, Schidt W, Urlich W. NO at work. Cell 1994; 78:919-925.
98. Zhang H, Rogiers P, Preiser J-C, Spapen H, Manikis P, Metz G, Vincent J-L. Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med 1995; 23:1711-1721.
99. ++ independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992; 105:575-580.
100. Kelly, RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res 1996; 79:363-380.
101. Balligand J-L, Cannon PJ. Nitric oxide and cardiac muscle. Autocrine and paracrine influences. Arterioscler Thromb Vasc Biol 1997; 17:24-35.
102. Balligand J-L, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA 1993; 90:347-351.
103. Corda S, Mebazaa A, Tavernier B, Ayed MB, Payen D. Paracrine regulation of cardiac myocytes in normal and septic hearts. J Crit Care 1998; 13:39-47.
104. Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H. Functional β3-adrenoceptor in the human heart. J Clin Invest 1996; 98:556-562.
105. Gauthier C, Leblais V, Kobzik L, Trochu J-N, Khandoudi N, Bril A, Balligand J-L, Le Marec H. The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 1998; 102:1377-1384.
106. ++ current is regulated by cGMPdependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 1991; 88:1197-1201.
107. Wahler GM, Dollinger SJ. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinases. Am J Physiol 1995; 268:C45-C54.
108. Shah AM, Spurgeon HA, Sollott SJ, Talo A, Lakatta EG. 8-bromo-cGMP reduces the myofilament response to calcium in intact cardiac myocytes. Circ Res 1994; 74:970-978.
109. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75:725-748.
110. Torres J, Darley-Usmar V, Wilson MT. Inhibition of cytochrome c oxidase turnover by nitric oxide: mechanism and implications for control of respiration. Biochem J 1995; 212:169-173.
111. Gross WL, Bak MI, Ingwall JS, Kelly RA, Balligand J-L, Smith TW. Nitric oxide regulates rat heart contractile reserve by reversible post-translational modification of creatine kinase. Proc Natl Acad Sci USA. 1996; 93:5604-5609.
112. Campbell DL, Stamler JS, Strauss HC. Redox modulation of the L-type cacium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 1996; 108:277-293.
113. Cunnion RE, Parrillo JE. Myocardial dysfunction in sepsis. Crit Care Clin 1989; 5:99-118.
114. Liu SF, Barnes PJ, Evans TW. Time course and cellular localization of lipopolysaccharideinduced inducible nitric oxide synthase messanger RNA expression in the rat in vivo. Crit Care Med 1997; 25:512-518.
115. Finkel TH, Oddis TD, Jacob SC, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-389.
116. Gurevitch J, Dfrolkis I, Yuhas Y, Paz M, Masta R, Yakirevich V. Tumor necrosis factoralpha is released from isolated heart undergiong ischemia and reperfusion. J Am Coll Cardiol 1996; 28:247-252.
117. Oral H, Dorn GW, Mann DL. Sphingosine mediates the immediate negaive inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. J Biol Chem 1997; 272:4836-4842.
118. Balligand J-L, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthaesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993; 91:2314-2319.
119. Simmons W, Closs E, Cunningham J, Smith T, Kelly R. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes: regulation of Larginine transport and no production of CAT-1, CAT-2A, and CAT-2B. J Biol Chem 1996; 271:11694-11702.
120. Mckenna T, Li S, Tao S. PKC mediates LPS- and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. Am J Physiol 1995; 269:H1891-H1898.
121. Singh K, Balligand J-L, Fischer T, Smith T, Kelly R. regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvacsular endothelial cells: role of extra cellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT 1 alpha. J biol Chem 1996; 271:1111-1117.
122. Lapointe M, Sitkins J. Mechanisms of interleukin-1 beta regulation of nitric oxide synthase in cardiac myocytes. Hypertension 1996; 27:709-714.
123. Brady AJB, Poole-Wilson PA, Harding SE, Waren JB. Nitric oxide- production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992; 263:H1963-H1966.
124. 2+]i and cell contraction in cultured chick ventricular myocytes. Circ Res 1994; 75:285-295.
125. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993; 265:H176-H182.
126. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD. The role of nitric oxide in cardiac depression induced by interleukin-1β and tumor nacrosis factor-β. Br J Pharmacol 1995; 114:27-34.
127. Herbertson MJ, Werner HA, Waley KR. Nitric oxide synthase inhibition partially prevents decreased LV contractility during endotoxemia. Am J Phsiol 1996; 270:H1979-H1984.
128. Kaszaki J, Wolford A, Bari F, Boros M, Parratt J, Nagy S. Effect of nitric oxide synthase inhibition on myocardial contractility in anesthetized normal and endotoxemic dogs. Shock 1996; 4:279-285.
129. Klabunde RE, Coston AF. nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock. Shock 1995; 3:73-78.
130. Meng X, Ao L, Brown JM, Fullerton DA, Banerjee A, Harken AH. Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock. Shock 1997; 7:111-118.
131. Toth I, Heard S. Nitric oxide does not mediate lipopolysaccharide induced myocardial depression in guinea pigs. Crit Care Med 1997; 25:684-688.
132. Hoch CE, Yin K, Yue G, Wong PY. Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Am J Physiol 1997; 272:H843-H850.
133. Ishihara S, Ward JA, Tasaki O, Pruitt BA Jr, Goodwin CW Jr. Mozingo DW, Cioffi WG Jr. Inhaled nitric oxide prevents left ventricular impairement during endotoxemia. J Appl Physiol 1998; 85:2018-2024.
134. Weyrich AS, Xin-liang M, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicolas JM, Thomas AP, Lefer D. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res 1994; 75:692-700.
135. Zhang H, Rogiers P, Friedman G, Preiser J-C, Spapen H, Buurman WA, Vincent J-L. Effects of nitric oxide donor SIN-1 in oxygen availability and regional blood flow during endotoxic shock. Arch Surg 1996; 131:767-774.
136. Afulukwe IF, Cohen RI, Zeballos GA, Iqbal M, Scharf SM. Selective NOS inhibition restores myocardial contractility in endotoxemic rats; however myocardial NO content does not correlate with myocardial dysfunction. Am J Resp Crit Care Med 2000; 162:21-26.
137. Billiar TR. Nitric oxide; novel biology with clinical relevance. Ann Surg 1995; 221:339-349.
138. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994; 78:931-936.
139. Kronke K-D, Fehsel K, Bachofen-Kolk V. Nitric oxide: Cytotoxicity versus cytoprotection- how, why, when, and where? Nitric Oxide Biol Chem 1997; 1:107-120.
140. Wink DA, Mitchell JB. Chemical biology of nitric oxide insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Rad Biol Med 1998; 25:434-456.
141. Deming RH, Lalonde PR, Ryan P, Zhu D, Liu Y. Endotoxemia produces an increase in arterial but not venous lipid peroxides in sheep. J Appl Physiol 1988; 64:592-598.
142. Minamiya Y, Abo S, Kiamura M, Keiichi I, Kimura Y, Tozawa K, Saito S. Endotoxininduced hydrogen peroxide production in intact pulmonary circulation of rat. Am J Respir Crit Care Med. 1995; 152:348-354.
143. Goode HF, Webster NR. Free radicals and antioxidants in sepsis. Crit Care Med 1993; 21:1770-1776.
144. Szabo C, Zingarelli B, Salzman A. Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 1996; 78:1051-1063.
145. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271:C1524-C1437.
146. Packer MA, Scarlett JL, Martin SW. Peroxynitrite: A biolgically significant oxidant. Gen Phamacol 1998; 31:179-186.
147. Koppenol WH. Moreno JL, Pryor WA, Ischiropoulus H, Beckman JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 1992; 5:834-842.
148. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactons by nitric oxide. J Biol Chem 1996; 271:40-47.
149. Radi R, Beckman JS, Brush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem 119; 266:4244-4250.
150. Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on NADPH oxidase. J Clin Invest 1992; 90:1116-1121.
151. Wink DA, Cook JA, Pacelli R, DeGraff W, Gamson J, Liembman J, Krishna M, Mitchell JB. The effect of various nitric-oxide donor agents on hydrogen peroxide-mediated toxicity:A direct correlation between nitric oxide formation and protection. Arch Biochem Biophys 1996; 331:241-248.
152. Chang J, Rao N, Markewitz BA, Hoidal JR, Michael JR. Nitric oxide donor prevents hydrogen peroxide mediated endothelial cell injury. Am J Physiol 1996; 270:L9231-L940.
153. Boughton-Smith NK, Hutcheson IR, Deakin AM, Whittle BJR, Moncada S. Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 1990; 191:485-488.
154. Kubes P. Ischemia-reperfusion in feline small intestines: a role for nitric oxide. Am J Physiol 1993; 264:G142-G149.
155. Christopher TA, Ma X, Lefer AM. Beneficial actions of S-nitroso-N-acetylpenicillamine, a nitric oxide donor, in murine traumatic shock. Shock 1994; 1:19-24.
156. Oyama J-I, Shimokawa H, Mommii H, Cheng X-S, Fukuyama N, Arai Y, Egashira K, Nakazawa H, Takeshita A. Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardail dysfunction in dogs in vivo. J Clin Invest 1998; 101:2207-2214.
157. Kooy NW, Lewis SJ, Royall JA, Ye YZ, Kelly DR, Beckman JS. Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med 1997; 25:812-819.
158. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynirite in the airways of asthmatic patients is associzted with the induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998; 12:929-937.
159. Mason NA, Springall DR, Pomerance A, Evans TJ, Yacoub MH, Polak JM. Expression of inducible nitric oxide synthase and formation of peroxynitite in posttransplant obliterative bronchiolitis. J Heart Lung Trans 1998; 17:710-714.
160. Pou Y, Nguyen SY, Gladwell T. Does peroxynitrite generate hydroxyl radical? Biochim Biophys Acta 1995; 244:62-68.
161. Taprey M, Beckman JS, Ischiropoulos H. Peroxynitrite stimulates vascular smooth muscle cell cGMP synthesis. FEBS Lett 1995; 354:314-318.
162. Thompson JA, Hell ML. The oxygen free radical system: a fundemental mechanism in the production of myocardial necrosis. Prog Cardiovasc Dis 1986; 28:449-462.
163. Cowan DB, Weisel RD, Williams WG, Mickle DA. The regulation of glutathione peroxidase gene expression by oxygen tension in cultured human cardiomyocytes. J Mol Cell Cardiol 1992; 24:423-433.
164. Asahi M, Fujii J, Suzuki K, Seo HG, Kuzuya T, Hori M, Tada M, Fujii S, Taniguchi N. Inactivation of glutathione peroxidase by nitric oxide; implications for cytotoxicity. J Biol Chem 1995; 270:21035-21039.
165. Igarashi J, Nishida M, Hoshida S, Yamashita N, Kosaka H, Hori M, Kuzuya T, Tada M. Inducible nitric oxide synthase augments injury elicited by oxidative stress in rat cardiac myocytes. Am J Physiol 1998; 274:C245.
166. Degnim AC, Morrow SE, Ku J, Zar HA, Nakayama DK. Nitric oxide inhibits peroxidemediated endothelial toxicity. J Surg Res 1998; 75:127-134.
167. Kuo PC, Slivka A. Nitric oxide decreases oxidant-mediated hepatocyte injury. J Surg Res 1994; 56:594-600.
168. Baldwin AS. The NF-κB and IκB proteins; new discoveries and insights. Annu Rev Immunol 1996; 14:640-681.
169. Liu SF, Ye X, Malik AB. In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 1997; 159:3976-3983.
170. Peng HB, Libby P, Liao JK. Induction and stabilization of IκBβ by nitric oxide mediates inhibition of NF-κB. J Biolol Chem 1995; 270:14214-14219.
171. Peng HB, Spiecker M, Liao JK. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol 1998; 161:1970-1976.
172. Kamijo R, Harada H, Matsuyama T, Rosland M, Gerecitano J, Shapiro D, Le J, Im KS, Kimura T, Green S, Mark TW, Taniguchi T, Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994; 263:1612-1615.
173. Martin E, Nathan C, Xie, Q-W. Role of interferon regulator facor 1 (IRF-1) in induction of nitric oxide synthase. J Exp Med 1994; 180:977-984.
174. Perrella JA, Yoshizumi M, Fen Z, Tsai JC, Hsieh C-M, Kourembanas S, Lee M-E. Transforming growth factor-β1, but not dexamethasone, down regulates nitric oxide synthase mRNA after its induction by interleukin-1βin rat smooth muscle cells. J Biol Chem 1994; 269:14595-14600.
175. Weiss G, Werner-Felmayer G, Werner ER, Grunwald K, Wachter H, Hentze MW. Iron regulates nitric xide synthase activity by controlling nuclear transcription. J Exp Med 1994; 180:969-976.